Cargando…
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
The identification of “trained immunity/tolerance” in myeloid cells has changed our perception of the performance of monocytes and macrophages during inflammatory and immune responses. Pemetrexed (PMX) and methotrexate (MTX) are blockers of the one-carbon metabolism (OCM) and commonly used therapeut...
Autores principales: | Fuentelsaz-Romero, Sara, Barrio-Alonso, Celia, García Campos, Raquel, Torres Torresano, Mónica, Muller, Ittai B., Triguero-Martínez, Ana, Nuño, Laura, Villalba, Alejandro, García-Vicuña, Rosario, Jansen, Gerrit, Miranda-Carús, María-Eugenia, González-Álvaro, Isidoro, Puig-Kröger, Amaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602851/ https://www.ncbi.nlm.nih.gov/pubmed/34804067 http://dx.doi.org/10.3389/fimmu.2021.776879 |
Ejemplares similares
-
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
por: Ríos, Israel, et al.
Publicado: (2022) -
Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism
por: Municio, Cristina, et al.
Publicado: (2018) -
Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate
por: Dawson, Alice, et al.
Publicado: (2006) -
Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages
por: Muller, Ittai B., et al.
Publicado: (2023) -
A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance
por: van der Krift, Felix, et al.
Publicado: (2023)